Ethibloc

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
The aim of this study is to assess the long-term results of Ethibloc injection in aneurysmal bone cysts (ABC). Thirty-three… (More)
Is this relevant?
2005
2005
The effects of percutaneous Ethibloc (Ethicon/Johnson & Johnson, St-Stevens-Woluwe, Belgium) injection into primary aneurysmal… (More)
Is this relevant?
2001
2001
Purpose: To assess the efficacy and long-term results of Ethibloc treatment in aneurysmal bone cysts (ABC). Methods: Thirteen… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2000
2000
Objective. To investigate whether the injection of Ethibloc into aneurysmal bone cysts can be an effective treatment modality… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Silymarin (SIL), a standardized plant extract containing about 60% polyphenole silibinin, is used as a hepatoprotective agent… (More)
Is this relevant?
1993
1993
Benign bone cysts often require treatment in order to prevent pathological fracture. We report preliminary experience with… (More)
  • table 1
  • figure I
Is this relevant?
1991
1991
Thirty-eight children with soft-tissue venous malformations (VMs) were treated with percutaneous injection of a new fibrosing… (More)
Is this relevant?
1990
1990
Twenty-one vascular malformations located in the facial area, 11 high-flow arteriovenous malformations and 10 slow-flow… (More)
Is this relevant?
1984
1984
In experimental and clinical use, Ethibloc in combination with 40% glucose preinjection has proven to be of major advantage in… (More)
Is this relevant?
1981
1981
Collateral vessels in tumors and arteriovenous malformations limit the effectiveness of therapeutic embolization. Capillary… (More)
Is this relevant?